Correlation Between Neuropace and INVO Old
Can any of the company-specific risk be diversified away by investing in both Neuropace and INVO Old at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Neuropace and INVO Old into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Neuropace and INVO Old, you can compare the effects of market volatilities on Neuropace and INVO Old and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Neuropace with a short position of INVO Old. Check out your portfolio center. Please also check ongoing floating volatility patterns of Neuropace and INVO Old.
Diversification Opportunities for Neuropace and INVO Old
Pay attention - limited upside
The 3 months correlation between Neuropace and INVO is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Neuropace and INVO Old in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on INVO Old and Neuropace is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Neuropace are associated (or correlated) with INVO Old. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of INVO Old has no effect on the direction of Neuropace i.e., Neuropace and INVO Old go up and down completely randomly.
Pair Corralation between Neuropace and INVO Old
If you would invest 1,087 in Neuropace on December 29, 2024 and sell it today you would earn a total of 151.00 from holding Neuropace or generate 13.89% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Flat |
Strength | Insignificant |
Accuracy | 0.0% |
Values | Daily Returns |
Neuropace vs. INVO Old
Performance |
Timeline |
Neuropace |
INVO Old |
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Neuropace and INVO Old Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Neuropace and INVO Old
The main advantage of trading using opposite Neuropace and INVO Old positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Neuropace position performs unexpectedly, INVO Old can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in INVO Old will offset losses from the drop in INVO Old's long position.Neuropace vs. Electromed | Neuropace vs. Orthopediatrics Corp | Neuropace vs. SurModics | Neuropace vs. Paragon 28 |
INVO Old vs. Entera Bio | INVO Old vs. NLS Pharmaceutics AG | INVO Old vs. Enveric Biosciences | INVO Old vs. Lixte Biotechnology Holdings |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.
Other Complementary Tools
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk |